menu search

Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights

Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights
NKX101 clinical update highlights encouraging antileukemic activity in patients with AML using fludarabine/cytarabine (Flu/Ara-C) lymphodepletion regimen NKX019 clinical data presented at EHA 2023 and ICML 2023 meetings Clinical updates planned for NKX019 in the second half of 2023 and NKX101 in the first half of 2024 Cash and cash equivalents of $302.2 million on June […] The post Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights appeared first on ForexTV... Read More
Posted: Aug 10 2023, 11:01
Author Name: forextv
Views: 022265

Search within

Pages Search Results: